Literature DB >> 15893183

Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.

John G F Cleland1, Amala A Louis, Alan S Rigby, Uwe Janssens, Aggie H M M Balk.   

Abstract

OBJECTIVES: We sought to identify whether home telemonitoring (HTM) improves outcomes compared with nurse telephone support (NTS) and usual care (UC) for patients with heart failure who are at high risk of hospitalization or death.
BACKGROUND: Heart failure is associated with a high rate of hospitalization and poor prognosis. Telemonitoring could help implement and maintain effective therapy and detect worsening heart failure and its cause promptly to prevent medical crises.
METHODS: Patients with a recent admission for heart failure and left ventricular ejection fraction (LVEF) <40% were assigned randomly to HTM, NTS, or UC in a 2:2:1 ratio. HTM consisted of twice-daily patient self-measurement of weight, blood pressure, heart rate, and rhythm with automated devices linked to a cardiology center. The NTS consisted of specialist nurses who were available to patients by telephone. Primary care physicians delivered UC. The primary end point was days dead or hospitalized with NTS versus HTM at 240 days.
RESULTS: Of 426 patients randomly assigned, 48% were aged >70 years, mean LVEF was 25% (SD, 8) and median plasma N-terminal pro-brain natriuretic peptide was 3,070 pg/ml (interquartile range 1,285 to 6,749 pg/ml). During 240 days of follow-up, 19.5%, 15.9%, and 12.7% of days were lost as the result of death or hospitalization for UC, NTS, and HTM, respectively (no significant difference). The number of admissions and mortality were similar among patients randomly assigned to NTS or HTM, but the mean duration of admissions was reduced by 6 days (95% confidence interval 1 to 11) with HTM. Patients randomly assigned to receive UC had higher one-year mortality (45%) than patients assigned to receive NTS (27%) or HTM (29%) (p = 0.032).
CONCLUSIONS: Further investigation and refinement of the application of HTM are warranted because it may be a valuable role for the management of selected patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893183     DOI: 10.1016/j.jacc.2005.01.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  159 in total

1.  HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.

Authors:  Andreas Von der Heidt; Elske Ammenwerth; Karl Bauer; Bettina Fetz; Thomas Fluckinger; Andrea Gassner; Willhelm Grander; Walter Gritsch; Immaculata Haffner; Gudrun Henle-Talirz; Stefan Hoschek; Stephan Huter; Peter Kastner; Susanne Krestan; Peter Kufner; Robert Modre-Osprian; Josef Noebl; Momen Radi; Clemens Raffeiner; Stefan Welte; Andreas Wiseman; Gerhard Poelzl
Journal:  Wien Klin Wochenschr       Date:  2014-11-13       Impact factor: 1.704

2.  Disease management programs for heart failure.

Authors:  Ken McDonald
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

3.  Remote heart failure monitoring.

Authors:  William T Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 4.  Disease monitoring of patients with chronic heart failure.

Authors:  M Gary Nicholls; A Mark Richards
Journal:  Heart       Date:  2007-04       Impact factor: 5.994

Review 5.  The vulnerable phase after hospitalization for heart failure.

Authors:  Stephen J Greene; Gregg C Fonarow; Muthiah Vaduganathan; Sadiya S Khan; Javed Butler; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

6.  Rationale and Design of EMPOWER, a Pragmatic Randomized Trial of Automated Hovering in Patients With Congestive Heart Failure.

Authors:  Shivan J Mehta; Kevin G Volpp; David A Asch; Lee R Goldberg; Louise B Russell; Laurie A Norton; Lauren G Iannotte; Andrea B Troxel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-04

7.  A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study.

Authors:  Owais Dar; Jillian Riley; Callum Chapman; Simon W Dubrey; Stephen Morris; Stuart D Rosen; Michael Roughton; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

8.  Randomized trial of Telemonitoring to Improve Heart Failure Outcomes (Tele-HF): study design.

Authors:  Sarwat I Chaudhry; Barbara Barton; Jennifer Mattera; John Spertus; Harlan M Krumholz
Journal:  J Card Fail       Date:  2007-11       Impact factor: 5.712

Review 9.  [ECG telemonitoring].

Authors:  Michael Oeff; Axel Müller; Jörg Neuzner; Stefan Sack; Jörg O Schwab; Dietrich Pfeiffer; Christian Zugck
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-10-25

Review 10.  Implantable devices to monitor patients with heart failure.

Authors:  Nikolaos Karamichalakis; John Parissis; George Bakosis; Vasiliki Bistola; Ignatios Ikonomidis; Antonios Sideris; Gerasimos Filippatos
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.